Norway
Commentary
Second Medical use Patents for Medicinal Products in the EU: When is Being Skinny not enough?
Author(s): Kleist N, Drouault-Gardrat P, Kavanagh C, Farrell C, Cappellaro E, Krag Iversen V, Austdal H, Borges A, Jausas H, Lofgren J, Mulryne J, Dodds- Smith I, Carbonell J, Vila E, Chryssospathis Y, Venaki R and Goldammer YKleist N, Drouault-Gardrat P, Kavanagh C, Farrell C, Cappellaro E, Krag Iversen V, Austdal H, Borges A, Jausas H, Lofgren J, Mulryne J, Dodds- Smith I, Carbonell J, Vila E, Chryssospathis Y, Venaki R and Goldammer Y
DOI:
10.4172/2167-7689.1000173
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 